Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.
1. A wearable augmented reality device comprising: an augmented reality head-mounted ophthalmic system comprising an augmented reality display platform comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted system; and a display attached to the frame, the display comprising: a waveguide stack configured to pass light from the world into an eye of the wearer; and a light source configured to provide light for generating virtual content, wherein the waveguide stack comprises a plurality of waveguides, each waveguide of the plurality of waveguides comprising: in-coupling diffractive optical elements configured to in-couple light provided by the light source, and out-coupling diffractive optical elements configured to out-couple in-coupled light to the eye of the wearer, wherein one or more waveguides of the plurality of waveguides are configured to output in-coupled light to an eye of the wearer with a different amount of wavefront divergence than one or more other waveguides of the plurality of waveguides, wherein different amounts of wavefront divergence are associated with different accommodation by the eye, and wherein the outputted light with different amounts of wavefront divergence forms virtual objects at different perceived depths away from the wearer, wherein each waveguide of the plurality of waveguides is configured to guide light therein by total internal reflection between opposing surfaces of the waveguide; and a medication delivery system configured to deliver medication to the eye of the wearer, wherein the augmented reality head-mounted ophthalmic system is configured to: display a visual cue on the display; and provide an alert to the wearer to focus on the visual cue while the medication is delivered.
A wearable augmented reality device integrates an augmented reality head-mounted display with a medication delivery system. The display system includes a frame worn on the head and a waveguide stack that allows light from the real world to pass through while also projecting virtual content. The waveguide stack consists of multiple waveguides, each with in-coupling and out-coupling diffractive optical elements that direct light from a light source into the wearer's eye. Different waveguides produce light with varying wavefront divergence, enabling the eye to accommodate at different depths, creating virtual objects at distinct perceived distances. Each waveguide guides light via total internal reflection between its surfaces. The device also includes a medication delivery system that administers medication to the wearer's eye. During medication delivery, the display shows a visual cue, and the system provides an alert prompting the wearer to focus on the cue, ensuring proper alignment and dosage. This combination of augmented reality and medication delivery enhances user experience and treatment accuracy.
2. The device of claim 1 , wherein the medication delivery system comprises outlets for expelling the medication, wherein the outlets are attached to the frame.
A medication delivery system is designed to administer medication to a patient, particularly for conditions requiring precise and controlled dosing. The system includes a frame that supports and positions the medication delivery components. The device features outlets for expelling the medication, which are securely attached to the frame. These outlets ensure accurate and consistent delivery of the medication to the intended site, whether it is a specific area of the body or a medical device. The frame provides structural stability, preventing misalignment or displacement of the outlets during operation. This design enhances the reliability and safety of medication administration, reducing the risk of dosing errors or improper delivery. The system may be used in various medical applications, including automated drug delivery, infusion systems, or targeted therapy devices, where precise control over medication flow is critical. The attachment of the outlets to the frame ensures that the delivery mechanism remains stable and functional, even under dynamic conditions. This configuration improves the overall performance of the medication delivery system, making it suitable for both clinical and home-use scenarios.
3. The device of claim 1 , wherein the augmented reality head-mounted ophthalmic system comprises a sensor to detect irritants in an atmosphere around the wearer, wherein the augmented reality head-mounted ophthalmic system is configured to deliver the medication based on the detection of the irritants.
This invention relates to an augmented reality (AR) head-mounted ophthalmic system designed to detect atmospheric irritants and automatically deliver medication to the wearer's eyes. The system integrates sensors capable of identifying airborne irritants such as pollen, dust, smoke, or chemical pollutants. Upon detection, the system triggers a medication delivery mechanism to administer therapeutic agents directly to the wearer's eyes, providing real-time protection against irritation or allergic reactions. The AR system may also include additional features such as environmental monitoring, user alerts, and adjustable medication dosages based on irritant levels. The primary goal is to enhance eye health by proactively responding to environmental hazards, reducing the need for manual intervention and improving wearer comfort in various settings. The system may be used in medical, industrial, or consumer applications where eye protection is critical.
4. The device of claim 1 , wherein the augmented reality head-mounted ophthalmic system is configured to deliver the medication to the eye of the wearer based on a treatment protocol.
This invention relates to an augmented reality (AR) head-mounted ophthalmic system designed to deliver medication to a wearer's eye according to a predefined treatment protocol. The system integrates AR technology with ophthalmic drug delivery, addressing the challenge of precise, automated medication administration for eye conditions. The device includes a head-mounted display that tracks the wearer's eye position and movement, ensuring accurate targeting of the medication. It also features a medication reservoir and a controlled dispensing mechanism that releases the medication in response to signals from the treatment protocol. The protocol may be customized based on factors such as dosage timing, frequency, and patient-specific requirements. The system may also include sensors to monitor eye health metrics, such as tear film stability or intraocular pressure, to adjust the treatment dynamically. By combining AR visualization with automated drug delivery, the invention aims to improve treatment adherence and efficacy for conditions like glaucoma, dry eye, or post-surgical care. The device may further incorporate feedback mechanisms, such as alerts or notifications, to confirm successful medication delivery or prompt user action if needed. The system's portability and real-time tracking capabilities enhance its usability for both clinical and home-based eye care.
5. The device of claim 1 , wherein the augmented reality head-mounted ophthalmic system is configured to provide an alert to the wearer while the medication is delivered.
This invention relates to an augmented reality (AR) head-mounted ophthalmic system designed to deliver medication to a user's eye while providing real-time visual feedback and alerts. The system includes a head-mounted display that projects AR content into the user's field of view, a medication delivery mechanism integrated into the device, and sensors to monitor the user's eye position and medication delivery status. The AR display provides visual guidance to ensure proper alignment of the medication delivery mechanism with the eye, reducing the risk of misapplication. The system is configured to deliver medication in a controlled manner, such as through a micro-dosing mechanism, to improve accuracy and user comfort. Additionally, the system generates alerts during medication delivery to notify the user of important events, such as successful application or potential errors. These alerts may include visual, auditory, or haptic feedback to ensure the user is aware of the delivery process. The invention aims to enhance medication adherence and accuracy for ophthalmic treatments, particularly for users with conditions requiring frequent or precise dosing. The system may also include connectivity features to log delivery data and transmit it to healthcare providers for monitoring and adjustment of treatment plans.
6. The device of claim 1 , wherein the augmented reality head-mounted ophthalmic system is configured to provide an alert to the wearer to keep the eye open while the medication is delivered.
This invention relates to an augmented reality (AR) head-mounted ophthalmic system designed to deliver medication to a user's eye while the user is engaged in AR activities. The system addresses the challenge of ensuring proper medication delivery to the eye, which requires precise alignment and timing to be effective. The device includes a medication delivery mechanism integrated into the AR headset, which dispenses medication directly to the user's eye. A tracking system monitors the user's eye position and blink rate to determine the optimal moment for delivery. The system is configured to provide real-time feedback to the user, including visual or auditory alerts, to ensure the eye remains open during medication administration. This prevents premature closure, which could disrupt the process. The AR interface may also display instructions or guidance to improve user compliance. The system may further include sensors to detect environmental conditions, such as lighting or humidity, to adjust delivery parameters accordingly. The invention ensures accurate and consistent medication delivery while maintaining the user's immersion in AR experiences.
7. The device of claim 1 , wherein the augmented reality head-mounted ophthalmic system is configured to deliver the medication as part of a light or laser therapy.
This invention relates to an augmented reality head-mounted ophthalmic system designed to deliver medication to a user's eyes as part of a light or laser therapy treatment. The system integrates augmented reality (AR) capabilities with ophthalmic drug delivery, addressing the challenge of administering precise, localized medication to the eye while maintaining user mobility and comfort. The AR head-mounted device includes a medication delivery mechanism that dispenses therapeutic agents directly to the eye, synchronized with light or laser therapy to enhance treatment efficacy. The system may incorporate sensors to monitor eye position, ensuring accurate medication delivery and therapy application. The AR functionality allows for real-time visualization of treatment progress, patient feedback, and interactive guidance, improving user compliance and treatment outcomes. The device is particularly useful for conditions requiring sustained or repeated ocular medication, such as dry eye disease, glaucoma, or post-surgical care, where traditional methods may be inconvenient or ineffective. By combining AR technology with targeted drug delivery and therapeutic light or laser treatment, the system provides a non-invasive, user-friendly solution for ocular therapy.
8. The device of claim 7 , wherein the medication is photosensitive to wavelengths of light used for the light or laser therapy.
This invention relates to a medical device for delivering light or laser therapy to a patient, where the medication administered to the patient is photosensitive to the specific wavelengths of light used in the therapy. The device includes a light or laser source configured to emit light at wavelengths that interact with the medication, enhancing its therapeutic effects. The device may also include a controller to regulate the light or laser output, ensuring precise and controlled exposure to the photosensitive medication. The system may further incorporate a delivery mechanism to administer the medication to the patient, either topically or systemically, depending on the treatment requirements. The device is designed to optimize the interaction between the light or laser therapy and the medication, improving treatment efficacy while minimizing potential side effects. The invention addresses the need for precise and controlled light-based therapies where the medication's response to specific wavelengths is critical for effective treatment.
9. A wearable augmented reality device comprising: an augmented reality head-mounted ophthalmic system comprising an augmented reality display platform comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted system; and a display attached to the frame, the display comprising: a waveguide stack configured to pass light from the world into an eye of the wearer; and a light source configured to provide light for generating virtual content, wherein the waveguide stack comprises a plurality of waveguides, each waveguide of the plurality of waveguides comprising: in-coupling diffractive optical elements configured to in-couple light provided by the light source, and out-coupling diffractive optical elements configured to out-couple in-coupled light to the eye of the wearer, wherein one or more waveguides of the plurality of waveguides are configured to output light to an eye of the wearer with a different amount of wavefront divergence than one or more other waveguides of the plurality of waveguides, wherein different amounts of wavefront divergence are associated with different accommodation by the eye, and wherein the outputted light with different amounts of wavefront divergence forms virtual objects at different perceived depths away from the wearer; and a liquid delivery system configured to deliver a liquid to the eye of the wearer, wherein the augmented reality head-mounted ophthalmic system is configured to: display a visual cue on the display; and provide an alert to the wearer to focus on the visual cue while the liquid is delivered.
A wearable augmented reality device integrates an augmented reality head-mounted display system with an ophthalmic liquid delivery system. The device includes a head-worn frame supporting a display that combines a waveguide stack and a light source. The waveguide stack contains multiple waveguides, each with in-coupling and out-coupling diffractive optical elements to direct light from the light source into the wearer's eye. Different waveguides produce light with varying wavefront divergence, enabling the eye to accommodate at different depths, thereby creating virtual objects at distinct perceived distances. The system also features a liquid delivery mechanism that dispenses liquid to the wearer's eye while displaying a visual cue and providing an alert to focus on it. This ensures proper eye alignment during liquid delivery, potentially addressing issues like dryness or other ophthalmic conditions while maintaining augmented reality functionality. The device combines augmented reality visualization with targeted eye care, enhancing user experience and eye health.
10. The device of claim 9 , wherein the liquid delivery system comprises outlets for expelling the liquid, wherein the outlets are attached to the frame.
This invention relates to a device for delivering liquid, particularly in a controlled and precise manner. The device includes a frame that supports a liquid delivery system, which is designed to distribute liquid through multiple outlets. These outlets are attached to the frame, ensuring stability and proper positioning during operation. The liquid delivery system may include components such as pumps, valves, or tubing to regulate the flow of liquid to the outlets. The frame provides structural support, allowing the device to maintain its shape and function under operational conditions. The outlets are strategically placed to direct the liquid to specific areas, which may be useful in applications such as irrigation, medical fluid delivery, or industrial processes. The design ensures efficient and accurate liquid distribution, minimizing waste and improving performance. The device may also incorporate additional features, such as sensors or controllers, to monitor and adjust the liquid flow as needed. The overall structure is compact and modular, allowing for easy assembly, maintenance, and customization based on specific requirements.
11. The device of claim 9 , wherein the liquid delivery system is configured to deliver a spray or mist of the liquid to the eye.
This invention relates to a device for delivering a liquid to the eye, addressing the need for precise and controlled application of therapeutic or lubricating liquids to the ocular surface. The device includes a liquid delivery system designed to dispense the liquid as a spray or mist, ensuring even distribution and minimizing waste. The system is integrated with a support structure that positions the device relative to the eye, allowing for accurate targeting. The liquid delivery system may include a reservoir for storing the liquid and a dispensing mechanism that releases the liquid in a controlled manner. The device may also incorporate sensors or feedback mechanisms to monitor the delivery process and adjust the spray or mist output as needed. The design ensures that the liquid is applied gently and effectively, reducing discomfort and improving treatment outcomes. The invention is particularly useful in medical or ophthalmic applications where precise liquid delivery is critical.
12. The device of claim 9 , wherein the liquid delivery system is configured to deliver drops of the liquid to the eye.
A liquid delivery system is designed to precisely administer drops of liquid to the eye, addressing the need for accurate and controlled ocular medication delivery. The system includes a reservoir to hold the liquid, a dispensing mechanism to release the liquid in controlled quantities, and a targeting mechanism to ensure the liquid is directed to the eye. The dispensing mechanism may use a pump, valve, or other controlled release method to produce consistent drop sizes. The targeting mechanism may include alignment guides, sensors, or automated positioning to ensure proper placement of the drops. The system may also incorporate feedback mechanisms to confirm successful delivery. This technology is particularly useful in medical applications where precise dosing and placement of eye drops are critical, such as in the treatment of glaucoma, dry eye syndrome, or post-surgical care. The system may be integrated into handheld devices, wearable eyewear, or automated dispensers to enhance usability and accuracy. The design ensures minimal waste, reduces the risk of contamination, and improves patient compliance by simplifying the administration process.
13. The device of claim 9 , wherein the liquid delivery system is configured to deliver a stream of the liquid to the eye.
This invention relates to a medical device for delivering liquid to the eye, addressing the challenge of precise and controlled administration of therapeutic or diagnostic liquids to ocular surfaces. The device includes a liquid delivery system designed to direct a stream of liquid specifically to the eye, ensuring accurate targeting and minimizing waste or spillage. The system may incorporate mechanisms to regulate flow rate, pressure, or droplet size, enhancing treatment efficacy and patient comfort. The device may also feature alignment or stabilization components to maintain proper positioning relative to the eye during use. Additionally, the liquid delivery system may be integrated with a support structure or housing that facilitates handheld operation or attachment to a larger medical apparatus. The invention aims to improve the accuracy and reliability of liquid-based eye treatments, such as drug delivery, irrigation, or diagnostic procedures, by providing a controlled and directed stream of liquid to the ocular surface.
14. The device of claim 9 , wherein the liquid delivery system is configured to deliver a saline solution to the eye of the wearer.
This invention relates to a wearable device for delivering a liquid solution to the eye of a wearer. The device addresses the problem of maintaining eye hydration and comfort, particularly for individuals who experience dryness or irritation due to environmental factors, prolonged screen use, or medical conditions. The device includes a liquid delivery system that dispenses a saline solution to the eye in a controlled manner, ensuring consistent hydration without causing discomfort or overhydration. The system is integrated into a wearable structure, such as eyewear or a head-mounted device, allowing for hands-free operation. The saline solution is stored in a reservoir within the device and is delivered through a conduit to the eye, where it is dispensed via a nozzle or applicator positioned near the eye. The device may also include sensors to monitor eye moisture levels and adjust the delivery rate accordingly, ensuring optimal hydration. The wearable design ensures the device remains stable and unobtrusive during use, making it suitable for daily wear. The invention improves upon existing eye hydration solutions by providing a more precise, automated, and user-friendly approach to maintaining eye health.
15. The device of claim 14 , wherein the ophthalmic system comprises a camera configured to image the eye and to detect an eye condition requiring the saline solution.
The invention relates to an ophthalmic system designed to monitor and treat eye conditions by delivering a saline solution. The system includes a camera configured to image the eye and detect conditions that necessitate the administration of saline solution. This camera captures visual data of the eye to identify specific conditions, such as dryness, irritation, or other abnormalities, that would benefit from saline treatment. The system also includes a saline solution delivery mechanism that dispenses the solution to the eye based on the detected condition. The delivery mechanism may be automated or manually controlled, ensuring precise and timely application of the saline solution to address the identified eye condition. The system may further include sensors or additional imaging components to enhance the accuracy of condition detection and treatment. The overall goal is to provide an integrated solution for real-time eye monitoring and therapeutic intervention, improving eye health and comfort.
16. The device of claim 15 , wherein the ophthalmic system is configured to detect dry eyes, and wherein the liquid delivery system is configured to deliver the saline solution when the eye is dry.
This invention relates to an ophthalmic system designed to detect dry eyes and automatically deliver a saline solution to alleviate dryness. The system includes a dry eye detection mechanism that monitors the eye for signs of dryness, such as reduced tear film stability or insufficient tear production. Once dryness is detected, a liquid delivery system dispenses a precise amount of saline solution to the eye. The delivery system may use a controlled release mechanism, such as a pump or microdispenser, to ensure accurate dosing. The system may also include a feedback loop to adjust the frequency or volume of saline delivery based on ongoing dry eye detection. The device is designed to be worn comfortably, possibly as part of a contact lens or eyewear, and may incorporate sensors to continuously monitor eye moisture levels. The invention aims to provide a proactive solution for dry eye syndrome, reducing discomfort and preventing long-term damage to the ocular surface.
17. The device of claim 14 , wherein the ophthalmic system is configured detect red or bloodshot eyes, and wherein the liquid delivery system is configured to deliver the saline solution in response to detection of the red or bloodshot eyes.
This invention relates to an ophthalmic system designed to detect and address red or bloodshot eyes. The system includes a detection mechanism that identifies redness or bloodshot conditions in the eyes, likely using image processing or sensor-based analysis. Upon detection, a liquid delivery system automatically dispenses a saline solution to the affected eye. The saline solution is stored in a reservoir and delivered through a nozzle or applicator positioned near the eye. The system may incorporate a user interface to allow manual activation or adjustment of the delivery settings. The detection and delivery processes are synchronized to ensure timely and precise application of the solution. The invention aims to provide an automated, non-invasive solution for eye redness, improving user convenience and effectiveness compared to manual methods. The system may be integrated into wearable devices, such as smart glasses or contact lens systems, or standalone units for home or clinical use. The saline solution helps reduce redness by flushing irritants or allergens from the eye surface, promoting faster relief and comfort. The system may also include safety features to prevent over-delivery or misuse, ensuring safe and controlled application.
18. The device of claim 9 , wherein the augmented reality head-mounted ophthalmic system further comprises one or more sensors to measure one or more of a temperature of the wearer, a duration since an immediately previous delivery of liquid or powdered medication to the eye, an ambient humidity, a presence of foreign objects on the eye, a presence of chemical irritants in the eyes, and/or a pollen or particulate count.
This invention relates to an augmented reality (AR) head-mounted ophthalmic system designed to monitor and treat eye conditions. The system includes sensors that detect various environmental and physiological factors affecting eye health. These sensors measure the wearer's body temperature, track the time elapsed since the last administration of liquid or powdered medication to the eye, assess ambient humidity levels, identify foreign objects on the eye, detect chemical irritants, and monitor pollen or particulate counts in the air. The system integrates these measurements to provide real-time feedback and automated treatment delivery. The sensors ensure precise and timely administration of medication, reducing the risk of eye irritation or infection. The AR interface may display alerts or treatment recommendations based on the sensor data, enhancing user awareness and compliance. This technology is particularly useful for individuals with chronic eye conditions, allergies, or those requiring frequent medication administration. The system improves eye health management by combining environmental monitoring, physiological tracking, and automated treatment delivery in a wearable device.
19. The device of claim 18 , wherein the augmented reality head-mounted ophthalmic system is configured to deliver the liquid to the eye based upon one or more measurements of the one or more sensors exceeding a threshold.
Augmented reality head-mounted ophthalmic systems are used to deliver therapeutic liquids to the eye, such as for treating dry eye disease. A key challenge is ensuring precise and timely delivery of the liquid to the eye based on real-time physiological data. This invention addresses this by incorporating sensors that monitor relevant eye parameters, such as tear film stability, blink rate, or corneal hydration. The system is configured to automatically dispense the liquid when sensor measurements exceed a predefined threshold, indicating a need for treatment. The sensors may include optical, electrical, or mechanical detectors integrated into the head-mounted device. The liquid delivery mechanism is synchronized with the sensor data to ensure accurate and responsive treatment. This approach improves the efficacy of dry eye therapy by providing on-demand liquid delivery based on objective measurements rather than manual intervention. The system may also include feedback mechanisms to adjust delivery parameters dynamically, ensuring optimal treatment outcomes. By integrating real-time sensing and automated delivery, the invention enhances the convenience and effectiveness of ophthalmic treatments in augmented reality environments.
20. The device of claim 18 , wherein the augmented reality head-mounted ophthalmic system is configured to flush the eye with the liquid.
An augmented reality head-mounted ophthalmic system is designed to provide real-time visual enhancements while also delivering therapeutic or diagnostic treatments to the eye. The system includes a head-mounted display that projects augmented reality content and integrates fluid delivery mechanisms to dispense a liquid, such as a therapeutic solution or diagnostic agent, directly onto the eye. This liquid can be used for flushing the eye, removing debris, or administering medication. The system ensures precise and controlled delivery of the liquid to the eye while maintaining the user's ability to view augmented reality content. The fluid delivery mechanism may include pumps, nozzles, or other dispensing components that are synchronized with the head-mounted display to ensure accurate targeting and application. The system may also include sensors to monitor eye position, ensuring the liquid is delivered effectively without obstructing the user's vision. This integration of augmented reality and ophthalmic treatment allows for simultaneous visual assistance and eye care, improving user experience and treatment outcomes.
Unknown
February 18, 2020
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.